1.
IRF3 and type I interferons fuel a fatal response to myocardial infarction
by King, Kevin R
Nature medicine, 2017, Vol.23 (12), p.1481-1487
2.
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
by Bidwell, Bradley N
Nature medicine, 2012, Vol.18 (8), p.1224-1231
3.
IRF FAMILY OF TRANSCRIPTION FACTORS AS REGULATORS OF HOST DEFENSE
by Taniguchi, Tadatsugu
Annual review of immunology, 2001, Vol.19 (1), p.623-655
4.
Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection
by Liehl, Peter
Nature medicine, 2014, Vol.20 (1), p.47-53
5.
Reducing Rates of Indeterminate Results in the Quantiferon-TB Gold Interferon Gamma Release Assay
by Kezlarian, Brie
American journal of clinical pathology, 2014, Vol.142 (suppl_1), p.A157-A157
6.
Mechanisms of type III interferon expression
by Iversen, Marie B
Journal of interferon & cytokine research, 2010, Vol.30 (8), p.573-578
7.
Beyond ISGlylation: Functions of Free Intracellular and Extracellular ISG15
by dos Santos, Paula Fernandes
Journal of interferon & cytokine research, 2017, Vol.37 (6), p.246-253
8.
Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity
by Liu, Manman
Clinical rheumatology, 2018, Vol.37 (10), p.2675-2684
9.
Interferon Alpha 2a and 2b in Ophthalmology: A Review
by Lewczuk, Natalia
Journal of interferon & cytokine research, 2019, Vol.39 (5), p.259-272
10.
Macrophages from Nonobese Diabetic Mouse Have a Selective Defect in IFN-γ but Not IFN-α/β Receptor Pathway
by Lee, Myung-Shik
Journal of clinical immunology, 2012, Vol.32 (4), p.753-761
11.
Macrophages: Their role, activation and polarization in pulmonary diseases
by Arora, Shweta Shweta
Immunobiology (1979), 2017, Vol.223 (4), p.383-396
12.
Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease
by Rice, Gillian I
Journal of clinical immunology, 2016, Vol.37 (2), p.123-132
13.
Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness
by Edwards, Michael R
Journal of allergy and clinical immunology, 2017, Vol.140 (4), p.909-920
14.
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyosi...
by Higgs, Brandon W
Annals of the rheumatic diseases, 2014, Vol.73 (1), p.256-262
15.
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
by Mathew, N.R
Nature medicine, 2018, Vol.24 (3), p.282-291
16.
S27 of IFNα1 Contributes to Its Low Affinity for IFNAR2 and Weak Antiviral Activity
by Sharma, Nikunj
Journal of interferon & cytokine research, 2019, Vol.39 (5), p.283-292
17.
PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production
by Zheng, Dahai
Cell research, 2008, Vol.18 (11), p.1105-1113
18.
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response
by TAKAOKA, Akinori
Nature, 2007, Vol.448 (7152), p.501-505
19.
Distinct Patterns of Expression of Transcription Factors in Response to Interferonβ and Interferonλ1
by Novatt, Hilary
Journal of interferon & cytokine research, 2016, Vol.36 (10), p.589-598
20.
Deficiency of Interferon-Gamma or Its Receptor Promotes Colorectal Cancer Development
by Wang, Lu
Journal of interferon & cytokine research, 2015, Vol.35 (4), p.273-280
